Publication | Open Access

Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling

MedicineLiver PhysiologyDrug DiscoveryComputational DiscoveryHepatocellular Carcinoma CellsNiclosamide EthanolamineHepatotoxicityAnti-cancer AgentDrug DevelopmentPharmacologyHepatocellular CarcinomaBiomolecular Engineering